.... and people still wonder why Mesoblast is looking to run another phase 3 COVID-19 ARDS trial in the USA ?
What happened to the cheaper alternatives like monoclonal antibodies or the Merck/Pfizer pills that were supposed to prevent people from ending up being admitted to hospital ?
Doesn't really look like they are working if the hospitalisation records from during the Delta peak has just been exceeded ?
https://www.reuters.com/world/us/us...italization-record-omicron-surges-2022-01-10/
U.S. breaks COVID-19 hospitalization record at over 132,000 as Omicron surges
There were 132,646 people hospitalized with COVID, surpassing the record of 132,051 set in January last year.
RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-70
-
- There are more pages in this discussion • 836 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |